Spero Therapeutics (SPRO) Q1 2025 Earnings

Mar 27Confirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-0.38
-0.27
-0.16
-0.04

Details

Expected EPS
-0.31
Actual EPS
-0.38
Surprise EPS
-0.07
Surprise Percent
-22.58%

Description

⁨Spero Therapeutics⁩ (⁦SPRO⁩) has reported earnings of ⁦-0.38⁩ per share for ⁦Q1 2025⁩.

0 Comments

Share your thoughts